382150 — OncoCross Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for OncoCross Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,008	16,642	20,751
Net Total Accounts Receivable
Net Total Receivables	36.1	46.8	300
Prepaid Expenses
Total Current Assets	7,196	16,763	21,101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	976	566	1,012
Net Intangible Assets
Other Long Term Assets
Total Assets	8,400	17,586	22,548
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,589	1,099	1,848
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	3,705	1,099	2,091
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	4,695	16,487	20,457
Total Liabilities & Shareholders' Equity	8,400	17,586	22,548
Total Common Shares Outstanding